Skip to main content
SpringerLink
Log in

Establishing the utility of biotech inventions

  • News Analysis
  • Published:
Bio/Technology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mitsuya, H., et al. 1985. Retroviruses in Human Lymphoma/Leukemia. M. Miwa, et al., eds., 277–288, Japan Sci. Soc. Press.

    Google Scholar 

  2. Sandstrom, E.G., and Kaplan, J.C. 1987. Drugs 34: 372–390.

    Article  CAS  Google Scholar 

  3. Paull, K.D., Nasr, M., and Narayanan, V.L. 1984. Arzneim-Forsch./Drug Res. 34(II): 1243–1246.

    Google Scholar 

  4. Pazdur,R., et al. 1984. Proceedings Am. Soc. Clin. Oncology 3: 219.

    Google Scholar 

  5. Martin, D.S., et al. 1986. Cancer Research 46: 2189–2192.

    CAS  PubMed  Google Scholar 

  6. U.S. Patent No. 4,614,820 for “3,6-Disubstituted-1,8-Naphthalimides”.

Download references

Author information

Author notes

  1. Kevin J. McGough of Bronxville, NY, is a patent attorney whose practice involves pharmaceutical and health-care matters.

    • Kevin J. McGough
Authors
  1. Kevin J. McGough
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGough, K. Establishing the utility of biotech inventions. Nat Biotechnol 12, 766–768 (1994). https://doi.org/10.1038/nbt0894-766

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0894-766

  • Springer Nature America, Inc.

Search

Navigation